Showing results (111-120 of 436) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|July 25, 2003
A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experienceJoth L Jacobson, Mohamad A Hussein, Bart Barlogie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's MacroglobulinemiaMu Hao, Bart Barlogie, Guido Tricot, et al.
Blood|October 24, 2002
Antimyeloma efficacy of thalidomide in the SCID-hu modelShmuel Yaccoby, Cherie L Johnson, Susan C Mahaffey, et al.
The New England Journal of Medicine|December 26, 2003
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myelomaErming Tian, Fenghuang Zhan, Ronald Walker, et al.
Blood|July 15, 2009
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growthAngela Pennisi, Wen Ling, Xin Li, et al.
Cancer|September 24, 2010
Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients: clinical and research implicationsSomashekar G Krishna, Weizhi Zhao, Monica L Grazziutti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2011
DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologiesGraham A Colditz, John Crowley
British Journal of Haematology|June 17, 2004
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myelomaJames Peter Stewart, Alexander Thompson, Madhumita Santra, et al.
Molecular Cancer Therapeutics|March 6, 2008
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myelomaErming Tian, Terry H Landowski, Owen W Stephens, et al.
Cancer Research|March 18, 2004
Cancer and the microenvironment: myeloma-osteoclast interactions as a modelShmuel Yaccoby, Michele J Wezeman, Aminah Henderson, et al.
Pageof 44